As of 2025-01-23, the Relative Valuation of Karyopharm Therapeutics Inc (KPTI) is (9.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.69 USD, the upside of Karyopharm Therapeutics Inc based on Relative Valuation is -1507.9%.
The range of the Relative Valuation is (9.72) - (12.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.7x - 19.9x | 10.6x |
| Forward P/E multiples | 14.0x - 18.3x | 17.4x |
| Fair Price | (9.72) - (12.70) | (9.67) |
| Upside | -1514.9% - -1948.9% | -1507.9% |
| Date | P/E |
| 2025-01-14 | -0.91 |
| 2025-01-13 | -0.97 |
| 2025-01-10 | -1.04 |
| 2025-01-08 | -1.03 |
| 2025-01-07 | -1.11 |
| 2025-01-06 | -1.20 |
| 2025-01-03 | -1.13 |
| 2025-01-02 | -1.17 |
| 2024-12-31 | -0.98 |
| 2024-12-30 | -1.01 |
| 2024-12-27 | -1.01 |
| 2024-12-26 | -0.87 |
| 2024-12-24 | -0.86 |
| 2024-12-23 | -0.89 |
| 2024-12-20 | -0.92 |
| 2024-12-19 | -0.94 |
| 2024-12-18 | -0.96 |
| 2024-12-17 | -0.96 |
| 2024-12-16 | -0.97 |
| 2024-12-13 | -1.01 |
| 2024-12-12 | -1.04 |
| 2024-12-11 | -1.05 |
| 2024-12-10 | -1.05 |
| 2024-12-09 | -1.11 |
| 2024-12-06 | -1.11 |
| 2024-12-05 | -1.15 |
| 2024-12-04 | -1.15 |
| 2024-12-03 | -1.17 |
| 2024-12-02 | -1.19 |
| 2024-11-29 | -1.22 |
| 2024-11-27 | -1.23 |
| 2024-11-26 | -1.26 |
| 2024-11-25 | -1.21 |
| 2024-11-22 | -1.22 |
| 2024-11-21 | -1.12 |
| 2024-11-20 | -1.12 |
| 2024-11-19 | -1.12 |
| 2024-11-18 | -1.15 |
| 2024-11-15 | -1.17 |
| 2024-11-14 | -1.21 |
| 2024-11-13 | -1.25 |
| 2024-11-12 | -1.30 |
| 2024-11-11 | -1.33 |
| 2024-11-08 | -1.26 |
| 2024-11-07 | -1.27 |
| 2024-11-06 | -1.28 |
| 2024-11-05 | -1.22 |
| 2024-11-04 | -1.35 |
| 2024-11-01 | -1.30 |
| 2024-10-31 | -1.43 |